Freddy Crossley
CEO of PL Cambridge Capital
Cambridge Capital
Cambridge Capital is Panmure Liberum’s specialist healthcare growth capital and advisory subsidiary for private companies
Transaction Advisory for Healthcare Companies
Panmure Liberum Cambridge Capital's experienced team supports private companies across the full funding lifecycle, including Series A, growth capital, venture debt, secondaries and pre-IPO rounds.
We manage the process from round preparation and investor outreach through to deal closing and beyond, connecting companies with our global network of investors, including specialist venture capital, growth and private equity, strategic and corporate venture, and sovereign wealth funds.
Our aim is to streamline the journey for CEOs and boards, providing support across each stage of the process. We also advise on and run M&A processes, both buy-side and sell-side.
Deep Experience in Healthcare
Panmure Liberum Cambridge Capital fields a team of expert advisers with decades of experience across healthcare and life sciences, covering a full range of transactions and investments.
We are focused on achieving successful outcomes for clients, with compensation aligned to transaction completion. The team is in constant contact with life sciences companies and a wide range of investors, giving us current market knowledge alongside deep sector experience.
Cambridge team
A selection of people connected to our Cambridge advisory and growth-company work.
Edward Rayner
Managing Director, PL Cambridge Capital
David Cox
Director, Specialist Sales, Healthcare